ATM-deficient Lung, Prostate and Pancreatic Cancer Cells Are Acutely Sensitive to the Combination of Olaparib and the ATR Inhibitor AZD6738

Genome Instability & Disease

doi 10.1007/s42764-020-00011-0

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Depletion of ATR Selectively Sensitizes ATM-deficient Human Mammary Epithelial Cells to Ionizing Radiation and DNA-damaging Agents

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Human Pancreatic Cancer Stem Cells Are Sensitive to Dual Inhibition of IGF-IR and ErbB Receptors

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

MTOR Inhibitor-Based Combination Therapies for Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

The PARP Inhibitor AZD2281 (Olaparib) Induces Autophagy/Mitophagy in BRCA1 and BRCA2 Mutant Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Inhibiting the McM8-9 Complex Selectively Sensitizes Cancer Cells to Cisplatin and Olaparib

Cancer Science
Cancer ResearchMedicineOncology
2019English

The Combination of Olaparib and Camptothecin for Effective Radiosensitization

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells

Cancers
Cancer ResearchOncology
2019English

The G2 Checkpoint Inhibitor CBP-93872 Increases the Sensitivity of Colorectal and Pancreatic Cancer Cells to Chemotherapy

PLoS ONE
Multidisciplinary
2017English

Synergistic Activities of MET/RON Inhibitor BMS-777607 and mTOR Inhibitor AZD8055 to Polyploid Cells Derived From Pancreatic Cancer and Cancer Stem Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy